Semaglutide May Reduce Asthma Attacks | Science News

New research reveals that weight loss and diabetes drugs like Ozempic and Wegovy—containing semaglutide—may slash asthma attacks by nearly 40%, with similar benefits seen in COPD flare-ups. Analyzing real-world health records, scientists found these GLP-1 agonists improve lung health, possibly by tackling the metabolic links to respiratory disease. Experts urge caution: this isn’t a prescription for lung conditions yet, but it highlights how managing metabolism could revolutionize respiratory care—and future trials may soon explore this connection more deeply. Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/75493d34fb6b7923